LDL cholesterol — how to read your number, and why the target depends on your risk

Q: What's a good LDL level?

There isn't one universal number. For lower-risk people, under ~100 mg/dL is commonly considered fine; for those with established heart disease or diabetes plus risk factors, guidelines target under 70 mg/dL or lower. Your personal target is set by your overall cardiovascular risk, so it's best decided with your clinician.

Q: Is LDL or ApoB the better test?

LDL cholesterol is the traditional and widely available marker. ApoB counts the actual number of atherogenic particles and can reveal risk that LDL underestimates — especially in people with high triglycerides, diabetes, or metabolic syndrome. Many clinicians now use ApoB to refine risk when the two might disagree.

Q: Do I need to fast for an LDL test?

Standard LDL is often calculated and can be affected by a recent fatty meal (mainly through triglycerides). Non-HDL cholesterol and ApoB are reliable without fasting. Many labs now accept non-fasting samples; follow the instructions on your specific order.

Q: My LDL is high but I feel fine — does it matter?

High LDL causes no symptoms until it contributes to a cardiovascular event, which is exactly why it's worth knowing and addressing early. The genetic and trial evidence shows that lowering LDL reduces cardiovascular risk, and that cumulative lifetime exposure matters — so a high number without symptoms is still meaningful.

Q: Can lifestyle alone lower my LDL?

Diet (reducing saturated fat, adding soluble fiber), weight loss, and exercise can lower LDL meaningfully for many people. How much, and whether medication is also needed, depends on your starting level and overall risk — very high or familial elevations usually need medication. This is an individualized decision.

Paired condition: High cholesterol lab work

Quick answer

LDL cholesterol ("low-density lipoprotein") is the lipid most directly tied to atherosclerosis — the buildup that causes heart attacks and strokes. The evidence that LDL *causes* cardiovascular disease is among the strongest in medicine. But there is no universal "normal" LDL: the right target depends on your overall risk, which is why the same number can be fine for one person and too high for another. LDL also undercounts risk in some people — which is where ApoB and Lp(a) come in.

Reference ranges and interpretation

Value / population	Classification	What it means
< 70 mg/dL	Target for high/very-high risk	Guideline target for people with established cardiovascular disease or diabetes with risk factors.
70 – 99 mg/dL	Near/above optimal	Often acceptable for lower-risk people; may still be too high if risk is elevated.
100 – 129 mg/dL	Above optimal	Borderline; interpretation depends on total risk profile.
130 – 159 mg/dL	Borderline high	Increasingly a target for lifestyle change and risk discussion.
160 – 189 mg/dL	High	Warrants evaluation; consider familial causes if persistent.
≥ 190 mg/dL	Very high	Suggests possible familial hypercholesterolemia; treatment usually recommended regardless of other risk.

Unlike many labs, LDL has no single healthy cutoff — the target is set by your cardiovascular risk. The bands above reflect common US clinical framing; your clinician sets your personal goal.

Why there's no single 'normal' LDL

For most lab tests, there's a reference range that's normal for nearly everyone. LDL is different. Because LDL causally drives atherosclerosis in a dose-and-time-dependent way, "how low is good" depends on how much other risk you carry.

A healthy 30-year-old with no risk factors and an LDL of 120 mg/dL is in a very different situation from a 60-year-old who has already had a heart attack and the same LDL of 120. For the second person, guidelines push LDL well below 70 mg/dL. That's why a lab report flagging your LDL as "normal" can be misleading — the software doesn't know your risk.

What different values typically indicate

≥ 190 mg/dL: very high, and a red flag for familial hypercholesterolemia (an inherited condition). Treatment is generally recommended regardless of other risk factors.

130 – 189 mg/dL: high to borderline-high. This is the range where a formal risk assessment — factoring in age, blood pressure, smoking, diabetes, and family history — guides whether lifestyle change alone or added medication is appropriate.

< 130 mg/dL: whether this is "good enough" depends entirely on your risk. For someone with established cardiovascular disease, even 100 is too high; guidelines target < 70 (and often lower).

The consistent theme across guidelines and the genetic evidence: for LDL, lower and earlier is better — but how aggressively to lower it is an individualized, risk-based decision, not a one-size cutoff.

What LDL misses — ApoB and Lp(a)

Standard LDL cholesterol measures the cholesterol carried inside LDL particles. But risk tracks more closely with the number of atherogenic particles, which is what ApoB measures. In people with diabetes, metabolic syndrome, or high triglycerides, LDL cholesterol can look reassuring while ApoB reveals a high particle count — a known blind spot.

Separately, Lp(a) [lipoprotein(a)] is a largely genetic, independent risk factor that a standard lipid panel doesn't capture. It's worth measuring at least once in a lifetime, especially with a family history of early heart disease.

If your LDL looks fine but you have metabolic risk or a strong family history, ApoB and a one-time Lp(a) fill in the picture LDL alone can't.

What to look at alongside LDL

A complete cardiovascular-lipid read includes:

- ApoB — the particle count; often a better risk marker than LDL cholesterol
- Lp(a) — measure once; genetic, independent risk
- HDL and triglycerides — the rest of the standard panel; the trig/HDL ratio flags insulin resistance
- Non-HDL cholesterol — total minus HDL; captures all atherogenic particles and needs no fasting
- hs-CRP — the inflammatory component of residual risk
- Blood pressure, HbA1c, smoking status, family history — the inputs to a formal risk estimate

LDL is the anchor, but the target and the plan come from the whole picture — not one line on the report.

Phi Longevity reads every marker on every lab you upload — together, against your history, against optimal ranges, and across time. The integrated picture tells you what a single number can't.

Start with my labs →

Frequently asked questions

What's a good LDL level?

There isn't one universal number. For lower-risk people, under ~100 mg/dL is commonly considered fine; for those with established heart disease or diabetes plus risk factors, guidelines target under 70 mg/dL or lower. Your personal target is set by your overall cardiovascular risk, so it's best decided with your clinician.

Is LDL or ApoB the better test?

LDL cholesterol is the traditional and widely available marker. ApoB counts the actual number of atherogenic particles and can reveal risk that LDL underestimates — especially in people with high triglycerides, diabetes, or metabolic syndrome. Many clinicians now use ApoB to refine risk when the two might disagree.

Do I need to fast for an LDL test?

Standard LDL is often calculated and can be affected by a recent fatty meal (mainly through triglycerides). Non-HDL cholesterol and ApoB are reliable without fasting. Many labs now accept non-fasting samples; follow the instructions on your specific order.

My LDL is high but I feel fine — does it matter?

High LDL causes no symptoms until it contributes to a cardiovascular event, which is exactly why it's worth knowing and addressing early. The genetic and trial evidence shows that lowering LDL reduces cardiovascular risk, and that cumulative lifetime exposure matters — so a high number without symptoms is still meaningful.

Can lifestyle alone lower my LDL?

Diet (reducing saturated fat, adding soluble fiber), weight loss, and exercise can lower LDL meaningfully for many people. How much, and whether medication is also needed, depends on your starting level and overall risk — very high or familial elevations usually need medication. This is an individualized decision.

References

All citations verified against PubMed / publisher of record (see note below for this page's verification date).

1.Grundy SM, Stone NJ, Bailey AL, et al. (2019). 2018 AHA/ACC/Multisociety Guideline on the Management of Blood Cholesterol. Circulation. 139(25):e1082-e1143. — Source for risk-based LDL targets, the ≥ 190 mg/dL familial-hypercholesterolemia framing, and the individualized-risk approach.PubMed →DOI →
2.Ference BA, Ginsberg HN, Graham I, et al. (2017). Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. European Heart Journal. 38(32):2459-2472. — The causality-and-cumulative-exposure evidence behind 'lower and earlier is better.'PubMed →DOI →
3.Mach F, Baigent C, Catapano AL, et al. (2020). 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. European Heart Journal. 41(1):111-188. — Risk-stratified LDL goals and the roles of ApoB and non-HDL cholesterol.PubMed →DOI →

LDL has no single 'normal' value — targets are risk-based and set individually. LDL is often calculated rather than directly measured, and ApoB or non-HDL cholesterol can better capture risk in some people. Every link opens the PubMed abstract or publisher's DOI landing page in a new tab. All citations verified vs PubMed / publisher of record 2026-07-18.

By Steve Pinedo

Co-founder, Phi Longevity

Last updated: 2026-07-18

Steve Pinedo is the Co-founder of Phi Longevity, the AI application that turns a confusing stack of lab reports, wearable data, and clinical notes into a single, integrated picture of your health. He started Phi Longevity to make proactive health and wellness far easier to achieve. He realized how difficult it was for clients to manage their own care, records and coordination so he assembled a comprehensive M.D. led clinical team behind the platform, packaging the proactive-care experience that delivered measurable outcomes (lower triglycerides, reduced body fat, improved LDL, balanced hormones, relief from long-running autoimmune conditions) for any patient with a complicated lab to use now with an application. More about Phi Longevity →

High cholesterol labs

The full lipid pattern this number lives in.

ApoB

The particle count that can refine LDL risk.

Triglycerides

The other half of the standard lipid panel.